Modulation of osteoblastogenesis by NRF2 : NRF2 activation suppresses osteogenic differentiation and enhances mineralization in human bone marrow‐derived mesenchymal stromal cells
The FASEB Journal · 2024
DOI: 10.1096/fj.202400602r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, 2024. Verfasst von Takahiro Onoki und 7 weiteren Autor:innen. Beteiligte Einrichtung: Bone and Joint Research Group, Centre for Human Development, Stem Cells and Regeneration, Institute of Developmental Sciences, University of Southamp…. Hauptthemen laut MEDLINE: NF-E2-Related Factor 2, Mesenchymal Stem Cells, Osteogenesis, Cell Differentiation. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: UK Regenerative Medicine Platform (UKRMP).
Abstract (Originalsprache)
Mesenchymal stromal stem cells (MSCs) or skeletal stem cells (SSCs) play a major role in tissue repair due to their robust ability to differentiate into osteoblasts, chondrocytes, and adipocytes. Complex cell signaling cascades tightly regulate this differentiation. In osteogenic differentiation, Runt‐related transcription factor 2 (RUNX2) and ALP activity are essential. Furthermore, during the latter stages of osteogenic differentiation, mineral formation mediated by the osteoblast occurs with the secretion of a collagenous extracellular matrix and calcium deposition. Activation of nuclear factor erythroid 2‐related factor 2 (NRF2), an important transcription factor against oxidative stress, inhibits osteogenic differentiation and mineralization via modulation of RUNX2 function; however, the exact role of NRF2 in osteoblastogenesis remains unclear. Here, we demonstrate that NRF2 activation in human bone marrow‐derived stromal cells (HBMSCs) suppressed osteogenic differentiation. NRF2 activation increased the expression of STRO‐1 and KITLG (stem cell markers), indicating NRF2 protects HBMSCs stemness against osteogenic differentiation. In contrast, NRF2 activation enhanced mineralization, which is typically linked to osteogenic differentiation. We determined that these divergent results were due in part to the modulation of cellular calcium flux genes by NRF2 activation. The current findings demonstrate a dual role for NRF2 as a HBMSC maintenance factor as well as a central factor in mineralization, with implications therein for elucidation of bone formation and cellular Ca 2+ kinetics, dystrophic calcification and, potentially, application in the modulation of bone formation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Bone and Joint Research Group, Centre for Human Development, Stem Cells and Regeneration, Institute of Developmental Sciences, University of Southampton, Southampton, UK.
- Department of Orthopaedic Surgery, Tohoku University School of Medicine, Sendai, Japan.
ORCID-Profile: Takahiro Onoki, Janos Kanczler, Andrew Rawlings, Melanie Smith, Yang-Hee Kim, Ko Hashimoto, Toshimi Aizawa, Richard O C Oreffo
Förderung
- UK Regenerative Medicine Platform (UKRMP)
Zitieren
APA
Onoki, T., Kanczler, J., Rawlings, A., Smith, M., Kim, Y. H., Hashimoto, K., Aizawa, T., & Oreffo, R. O. C. (2024). Modulation of osteoblastogenesis by NRF2 : NRF2 activation suppresses osteogenic differentiation and enhances mineralization in human bone marrow‐derived mesenchymal stromal cells. The FASEB Journal. https://doi.org/10.1096/fj.202400602r
Vancouver
Onoki T, Kanczler J, Rawlings A, Smith M, Kim YH, Hashimoto K, et al. Modulation of osteoblastogenesis by NRF2 : NRF2 activation suppresses osteogenic differentiation and enhances mineralization in human bone marrow‐derived mesenchymal stromal cells. The FASEB Journal. 2024. doi:10.1096/fj.202400602r
BibTeX
@article{Onoki2024,
author = {Onoki, Takahiro and Kanczler, Janos and Rawlings, Andrew and Smith, Melanie and Kim, Yang-Hee and Hashimoto, Ko and Aizawa, Toshimi and Oreffo, Richard O C},
title = {Modulation of osteoblastogenesis by NRF2 : NRF2 activation suppresses osteogenic differentiation and enhances mineralization in human bone marrow‐derived mesenchymal stromal cells},
journal = {The FASEB Journal},
year = {2024},
doi = {10.1096/fj.202400602r}
}
EUVIMED